FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

SILVER SPRING, Md., Feb. 13, 2018 /PRNewswire-USNewswire/ -- Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT ......

Read more...

Posted under: Software - Tuesday, 13 February, 2018